Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Sol…

Medical - Diagnostics & Research

US, Waltham [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about Thermo Fisher Scientific Inc.'s gradings, price targets and earnings estimates. None

Earnings
Grading & Price

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2014	-	6.350	-	16,144	-	1,805	-	4,043	-	2,376	-	4,663
2015	-	7.384	-	16,866	-	1,947	-	3,977	-	2,303	-	4,547
2016	-	8.241	-	18,299	-	3,197	-	5,139	-	3,741	-	3,141
2017	-	9.359	-	20,588	-	3,631	-	5,782	-	4,209	-	3,534
2018	-	11.052	-	24,078	-	2,837	-	5,935	-	3,653	-	5,843
2019	-	12.332	-	25,488	-	3,635	-	6,897	-	4,520	-	6,036
2020	-	19.029	-	31,119	-	5,382	-	8,552	-	6,566	-	5,962
2021	-	23.541	-	37,257	-	9,134	-	10,464	-	7,616	-	6,396
2022	-	23.037	-	43,879	-	4,695	-	7,886	-	6,061	-	6,317
2023	-	21.521	-	42,748	-	5,995	-	9,285	-	7,064	-	7,524
2024	-	21.696	-	42,817	-	8,418	-	12,026	-	8,753	-	7,350
2025	-	23.565	-	45,140	-	9,139	-	12,678	-	9,228	-	7,749
2026	-	26.238	-	48,479	-	10,211	-	13,616	-	9,911	-	8,322
2027	-	29.507	-	52,093	-	1.F13X/td>	-	1.F131/td>	-	1.F131	-	1.F131
2028	-	33.325	-	56,052	-	0.F14X/td>	-	0.F141/td>	-	0.F141	-	0.F141